Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
University of Santo Tomas Hospital · Hospital Británico de Buenos Aires · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,030
total citations
- FWCI
- 99.83
- Percentile
- 100%
- References
- 42
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Belimumab
- Medicine
- B-cell activating factor
- Internal medicine
- Placebo
- Clinical endpoint
- Systemic lupus erythematosus
- Lupus erythematosus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.